A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program
Part of paid clinical trials in New York, New York.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT05748158
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 59 Years
- Healthy Volunteers
- Not accepted
Interventions
- Weight loss — BEHAVIORALA behavioral lifestyle program, up to 20 weeks in duration, based on interventions shown to be successful for weight loss such as the Diabetes Prevention Program (DPP), Action for Health in Diabetes (Look AHEAD), and Comprehensive Assessment of the Long-term Effects of Reducing Intake of Energy Study (CALERIE). Weekly sessions, led by experienced interventionists, will provide education and behavioral strategies for weight loss focused an energy-reduced diet and physical activity. Participants must meet the following milestones to continue in the study: * ≥ 2% weight loss anytime between 28 and 34 days after the start of the intervention * ≥ 5% weight loss anytime between 140 and 146 days after the start of the intervention * ≥ 7% weight loss by the end of 35 weeks After achieving ≥7% weight loss followed by weight stability, participants are observed, without further intervention, for 52 weeks.
Study Details
The goal of this clinical trial is to determine the physiological basis for the differences in weight regain among adults (25-59 years old) with obesity following participation in a behavioral weight loss program. Eligible participants will undergo a baseline evaluation after which they will enter an up to 20 week behavioral weight loss program with the goal of losing at least 7 percent of their baseline weight within 35 weeks. Participants who meet the weight loss goal will be asked to remain weight stable for 2 weeks after which they will undergo a clinical examination. They will then be observed for 1 year during which they will undergo 2 additional clinical examinations, one 4 months after completing the weight loss program, and the other 12 months after completing the weight loss program.
Key Dates
- Start date
- Sep 29, 2023
- Status verified
- Jun 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 205 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Other: Weight lossA 37 week behavioral intervention aimed at decreasing energy intake and increasing physical activity.
Primary Outcome Measure
Weight change from end of weight stabilization following at least 7 percent weight loss to 52 weeks after weight stabilization following at least 7 percent weight loss [ Time Frame: End of weight stabilization following at least 7 percent weight loss vs. 52 weeks after weight stabilization following at least 7 percent weight loss ]
Central Contacts
- Andrew Pelesko, BS412-383-9584
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 | Dympna Gallagher, EdD Rudolph Leibel, MD Rudolph Leibel, MD (PRINCIPAL_INVESTIGATOR) Dympna Gallagher, EdD (PRINCIPAL_INVESTIGATOR) Michael Rosenbaum, MD (PRINCIPAL_INVESTIGATOR) Laurel Mayer, MD (PRINCIPAL_INVESTIGATOR) |
| Drexel University | Philadelphia | Pennsylvania | 19104 | Michael R Lowe, PhD Michael R Lowe, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Matthew Hayes, PhD Kelly Allison, PhD Matthew Hayes, PhD (PRINCIPAL_INVESTIGATOR) Kelly Allison, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.Recruiting · Columbia University · Boston, Massachusetts
- Circadian Misalignment and Energy BalanceRecruiting · Columbia University · New York, New York
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)PHASE2 · Enrolling By Invitation · Memorial Sloan Kettering Cancer Center · New York, New York